Kết quả sớm của thay van động mạch chủ qua da bằng van tự bung hydra thv trong các ca bệnh có giải phẫu khó: báo cáo loạt 3 ca
Tóm tắt
Từ khóa
#Thay van động mạch chủ qua da #van Hydra #van tự bung #kỹ thuật van trong van #hẹp van động mạch chủ nặngTài liệu tham khảo
Otto CM, et al. 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease. Circulation. 2021.
Vahanian A, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022.
VARC-3 Writing Committee. VARC-3: Updated standardized endpoint definitions for TAVI. Eur Heart J. 2021.
Mack MJ, et al. Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3). N Engl J Med. 2023.
Pibarot P, et al. Hemodynamic performance and clinical outcomes after contemporary TAVI (updates/analyses 2020–2024). JACC/EHJ, 2020–2024.
Ribeiro HB, et al. Coronary obstruction after TAVI: contemporary review and management. (JACC/EuroIntervention review, 2020–2023).
Khan JM, et al. BASILICA technique and outcomes for prevention of coronary obstruction. (JACC/EuroIntervention, 2020–2022).
Tang GHL, et al. Coronary protection strategies in high-risk anatomy for TAVI. (JACC Cardiovasc Interv, 2020–2023).
Landes U, et al. PCI in patients undergoing TAVI: updated evidence and contemporary practice. (JACC, 2020–2022).
Webb JG, et al. Valve-in-valve TAVI: outcomes and considerations in small surgical bioprostheses. (JACC/EuroIntervention, 2020–2023).
“Hydra CE Study Investigators.” Clinical outcomes of the Hydra self-expanding transcatheter aortic valve (CE study). JACC: Cardiovascular Interventions. 2022.
Bapat V, et al. Hydra THV: mid-term/3-year evaluation in real-world practice. 2024 report.
Genereux P, et al. Vascular complications and closure strategies in contemporary TAVI practice. (JACC/EHJ, 2020–2023).
Barbanti M, et al. Patient-prosthesis mismatch after TAVI and valve-in-valve: definitions and outcomes. (Eur Heart J/JACC, 2020–2024).
Special topic update. CT planning metrics (VTTC, sinus sequestration risk, STJ constraints) and coronary access after TAVI. (EuroIntervention/JACC, 2020–2024).